...
  • 主题
高级搜索  >
历史搜索 清空历史
首页> 外文期刊>Journal of endovascular surgery: the official journal of the International Society for Endovascular Surgery >Clinical experience with superior vena caval Greenfield filters.
【24h】

Clinical experience with superior vena caval Greenfield filters.

机译：具有出色的腔静脉Greenfield过滤器的临床经验。

获取原文
获取原文并翻译 | 示例
           
页面导航
  • 摘要
  • 著录项
  • 相似文献
  • 相关主题

摘要

PURPOSE: To evaluate the results of superior vena caval (SVC) Greenfield filters in patients at risk for pulmonary embolism (PE) secondary to upper extremity deep venous thrombosis (UEDVT). METHODS: Over a 46-month period, 26 patients (10 men, mean age 67 years, range 25 to 89) with UEDVT in whom anticoagulation was contraindicated (n = 22) or ineffective in preventing recurrent PE or extension of the thrombus (n = 4) were treated with placement of SVC Greenfield filters. RESULTS: One SVC filter was misplaced into the innominate vein but left in place; this vein remains patent after 2 months without evidence of filter migration. Follow-up ranged from 10 days to 46 months (mean 7.8 months). Fifteen (58%) patients died inhospital of causes unrelated to the SVC filter or recurrent thromboembolism (mean time to death 36 days). Of the 11 survivors, follow-up ranged from 1 to 38 months (mean 22). Sequential chest roentgenograms in 9 (82%) patients revealed no filter migration or displacement. No evidence of PE was found in any of the survivors over the course of follow-up. CONCLUSIONS: Insertion of SVC Greenfield filters is a safe and feasible therapy to prevent recurrent thromboembolism in patients with UEDVT who are refractory to or inappropriate for anticoagulation therapy.
机译：目的：评估上腔静脉（SVC）Greenfield滤器在上肢深静脉血栓形成（UEDVT）继发肺栓塞（PE）风险患者中的结果。方法：在46个月的时间里，有26例UEDVT患者（10名男性，平均年龄67岁，范围从25到89），禁忌使用抗凝剂（n = 22）或不能有效预防PE复发或血栓延长（n = 4）放置了SVC Greenfield过滤器。结果：一个SVC过滤器被错放到无名静脉中，但仍留在原处。该静脉在2个月后仍保持专利，没有过滤器迁移的迹象。随访时间为10天至46个月（平均7.8个月）。 15例（58％）患者因与SVC过滤器或复发性血栓栓塞无关的死因住院（平均死亡时间为36天）。在11名幸存者中，随访时间为1至38个月（平均22个月）。 9例（82％）患者的胸部胸部X线照片显示无滤器迁移或移位。在随访过程中，任何幸存者均未发现PE。结论：插入SVC Greenfield滤器是一种安全可行的疗法，可防止难治性或不适合抗凝治疗的UEDVT患者复发性血栓栓塞。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱：kefu@zhangqiaokeyan.com

京公网安备：11010802029741号 ICP备案号：京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有

  • 客服微信

  • 服务号